LRIG1 Polyclonal Antibody
Product Specifications
Background
The LRRs and the Ig-domains are each sufficient for EGFR/ERBB1 binding. This interaction is abolished only when these two domains are deleted.,Act as a feedback negative regulator of signaling by receptor tyrosine kinases, through a mechanism that involves enhancement of receptor ubiquitination and accelerated intracellular degradation.,induction:By EGF.,Contains 17 LRR (leucine-rich) repeats.,Contains 3 Ig-like C2-type (immunoglobulin-like) domains.,subunit:Interacts with EGFR/ERBB1, ERBB2, ERBB3 and ERBB4.,tissue specificity:Widely expressed.,
CAS Number
9007-83-4
Synonyms
Leucine-rich repeats and immunoglobulin-like domains protein 1 ;LIG-1
Host
Rabbit
Reactivity
Human, Mouse
Immunogen
Synthesized peptide derived from part region of human protein
Clonality
Polyclonal
Applications
WB, ELISA
Stability
-20°C for 1 year
Concentration
1 mg/ml
Antibody Type
Primary antibody
Isotype
IgG
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
043315-FITC 200 µL
TSC1, phosphorylated (S312) (Tsc1, Kiaa0243, Hamartin, Tuberous sclerosis 1 protein homolog) (FITC) discontinued
Sign In for Pricing
View Details 
GTR15395249 1 Vial
Lentiviral human ELAVL1 sgRNA gene knockout kit - Lentiviral human ELAVL1 sgRNA gene knockout kit (plasmid)
Sign In for Pricing
View Details